These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17620092)

  • 1. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.
    Akilov OE; Kosaka S; O'Riordan K; Hasan T
    Exp Dermatol; 2007 Aug; 16(8):651-60. PubMed ID: 17620092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell accumulation and antileishmanial effect of exogenous and endogenous protoporphyrin IX after photodynamic treatment.
    Mateus JE; Valdivieso W; Hernández IP; Martínez F; Páez E; Escobar P
    Biomedica; 2014; 34(4):589-97. PubMed ID: 25504248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Macrophage Activation Markers in an Experimental Model of Cutaneous Leishmaniasis Treated with Photodynamic Therapy Mediated by 5-Aminolevulinic Acid.
    Silva MLF; Alves PM; Souza DM; Silva MV; Dos Santos JP; Paulino TP; Rodrigues DB; Rodrigues V
    Photobiomodul Photomed Laser Surg; 2019 May; 37(5):298-304. PubMed ID: 31084559
    [No Abstract]   [Full Text] [Related]  

  • 4. A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis.
    Kosaka S; Akilov OE; O'Riordan K; Hasan T
    J Invest Dermatol; 2007 Jun; 127(6):1546-9. PubMed ID: 17218937
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
    Tsai JC; Chen IH; Wong TW; Lo YL
    Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior.
    Fang YP; Huang YB; Wu PC; Tsai YH
    Eur J Pharm Biopharm; 2009 Nov; 73(3):391-8. PubMed ID: 19660544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
    Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
    J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
    Calin MA; Gruia Ml; Herascu N; Coman T
    J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
    Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
    Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer.
    Chen X; Zhao P; Chen F; Li L; Luo R
    Lasers Med Sci; 2011 Jan; 26(1):69-78. PubMed ID: 20676910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation.
    Akilov OE; Kosaka S; O'Riordan K; Hasan T
    Photochem Photobiol Sci; 2007 Oct; 6(10):1067-75. PubMed ID: 17914480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
    Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
    J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of photodynamic therapy in cutaneous leishmaniasis.
    van der Snoek EM; Robinson DJ; van Hellemond JJ; Neumann HA
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):918-22. PubMed ID: 18624853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence kinetics of protoporphyrin-IX induced from 5-ALA compounds in rabbit postballoon injury model for ALA-photoangioplasty.
    Kwon OC; Yoon HJ; Kim KH; Kim HT; Yoon YH; Kim JK
    Photochem Photobiol; 2008; 84(5):1209-14. PubMed ID: 18363621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
    Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
    Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy.
    Fan Z; Cui X; Wei D; Liu W; Li B; He H; Ye H; Zhu N; Wei X
    Sci Rep; 2016 May; 6():25353. PubMed ID: 27150264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
    Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
    J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
    de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.